Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia
Clinical trial NCT00695903 · TERMINATED
Trial details
- NCT number
- NCT00695903
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-17
- Primary completion
- 2010-08-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.